Madrigal Pharmaceuticals, Inc. (Madrigal Pharmaceuticals Inc. R) aksje
YDO1.F
Forsinket 15 min€400.10-12.90 (-3.12%)
Laster graf...
Madrigal Pharmaceuticals Inc. R
Market Cap
$9,224,569,856
Åpning408.10
Høy419.80
Lav397.60
Volum5
P/EN/A
Markedsverdi9.22B
52-ukers høy523.20
52-ukers lav235.70
Gj.sn. volum8
UtbytteN/A
Beta-1.04
EPS-11.56
Om Madrigal Pharmaceuticals, Inc. (Madrigal Pharmaceuticals Inc. R) aksje
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Selskapsinformasjon
Børs: Frankfurt (FRA)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
Four Tower Bridge
19428 West Conshohocken, United States
19428 West Conshohocken, United States
Telefon: + 267 824 2827
Nettside: https://www.madrigalpharma.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål